Fatty acid-binding protein 4 (FABP4)
|
−.41
|
−.49
|
−.32
|
<0.0001
|
−.17
|
−.25
|
−.09
|
<0.0001
|
Interleukin-6 (IL-6)
|
−.34
|
−.43
|
−.25
|
<0.0001
|
−.21
|
−.31
|
−.10
|
0.00015
|
Leptin
|
−.36
|
−.43
|
−.29
|
<0.0001
|
−.09
|
−.15
|
−.04
|
0.001
|
Galanin
|
.25
|
.16
|
.35
|
<0.0001
|
.18
|
.07
|
.29
|
0.002
|
Cystatin-B (CSTB)
|
−.31
|
−.40
|
−.21
|
<0.0001
|
−.16
|
−.27
|
−.05
|
0.0046
|
Interleukin-1 receptor antagonist protein (IL-1RA)
|
−.39
|
−.48
|
−.30
|
<0.0001
|
−.13
|
−.23
|
−.03
|
0.0085
|
Kallikrein-6 (KLK6)
|
.18
|
.08
|
.27
|
0.0003
|
.15
|
.03
|
.26
|
0.012
|
Heparin-binding EGF-like growth factor (HB-EGF)
|
.18
|
.08
|
.28
|
0.00029
|
.12
|
.01
|
.24
|
0.037
|
Growth/differentiation factor 15 (GDF-15)
|
−.19
|
−.29
|
−.09
|
0.00013
|
−.11
|
−.23
|
.00
|
0.049
|
Tissue-type plasminogen activator (t-PA)
|
−.33
|
−.42
|
−.24
|
<0.0001
|
−.10
|
−.19
|
.00
|
0.054
|
Cathepsin D (CTSD)
|
−.26
|
−.35
|
−.17
|
<0.0001
|
−.04
|
−.14
|
.06
|
0.46
|
Hepatocyte growth factor (HGF)
|
−.25
|
−.35
|
−.16
|
<0.0001
|
−.02
|
−.13
|
.08
|
0.67
|
E-selectin (SELE)
|
−.23
|
−.33
|
−.14
|
<0.0001
|
−.07
|
−.18
|
.04
|
0.20
|
Stem cell factor (SCF)
|
.23
|
.13
|
.32
|
<0.0001
|
.10
|
−.01
|
.22
|
0.073
|
Vascular endothelial growth factor D (VEGF-D)
|
.18
|
.09
|
.27
|
<0.0001
|
.06
|
−.04
|
.16
|
0.26
|
Follistatin (FS)
|
−.19
|
−.29
|
−.09
|
0.00012
|
−.07
|
−.18
|
.05
|
0.25
|
Fibroblast growth factor 23 (FGF-23)
|
−.17
|
−.27
|
−.08
|
0.0004
|
−.10
|
−.21
|
.01
|
0.084
|
Tumor necrosis factor ligand superfamily member 14 (TNFSF14)
|
−.17
|
−.27
|
−.07
|
0.00057
|
.04
|
−.07
|
.15
|
0.47
|